One-year cumulative toxicity in 25 prostate cancer patients treated with single fraction (24 Gy) urethra-sparing radiosurgery (PRO-FAST NCT05936736 )
Andrei Fodor, Italy | ESTRO | 2026
Cyberknife UH-SBRT for localized Prostate cancer and DIL: preliminary report of acute and late side effects of the prospective PRO-SPEED trial
Karl Amin, Italy | ESTRO | 2026
EARLY FINDINGS FROM THE STARR (NCT05455736) TRIAL:STEREOTACTIC SALVAGE RADIOTHERAPY FOR MACROSCOPIC RECURRENCE IN THE PROSTATE BED POST-PROSTATECTOMY
Niccolo’ Bertini | ESTRO | 2026
Impact of alternating-day fractionation on treatment outcome and toxicity in CyberKnife prostate SBRT
Michaela Jindráková, Czech Republic | ESTRO | 2026
Stereotactic body radiation therapy for intermediate-risk prostate cancer: efficacy and toxicity
María Dolores Espinosa Cuesta | ESTRO | 2026
DVH-based analysis of genitourinary side effects in robotic SBRT prostate treatments
David Sevillano, Spain | ESTRO | 2026
Planning, patient QA and image-guidance aspects of single-fraction, one-Day robotic SBRT for localized prostate cancer.
SARA BROGGI, Italy | ESTRO | 2026
Cyberknife Radiosurgery of Prostate Cancer – Results for 200 Patients
Sebastian Exner, Germany | ESTRO | 2026
Correlations of biochemical and clinical outcomes with 10-year results after robotic stereotactic body radiotherapy for localized prostate cancer
Kim JS , Park Y, Park HJ, Jang WI, Jeong BK, Kim H-J, Chang AR. Radiat Oncol. 2025 Oct 23;20(1):157. doi: 10.1186/s13014-025-02739-z. PMID 41131547
Frameless Robotic Radiosurgery System Stereotactic Body Radiation Therapy (SBRT) Dose Escalation Prostate Cancer Trial (CK-DESPOT) for Unfavorable Intermediate and High-Risk
Mark Nguyen et al. | ASTRO | 2025
Urethra Sparing in Robotic SBRT for Localized Prostate Cancer with Simultaneous Focal Boost to MR-Defined High PI-RADS Score Intra-Prostatic Lesions: A Dosimetric Analysis
Hong Xiang et al. | ASTRO | 2025
Reirradiation with SBRT in Radiorecurrent Prostate Cancer: Impact on Disease Control and Quality of Life Outcomes
Papaiah Sridhar et al. | ASTRO | 2025
PSMA Based Dose Escalation to Dominant Intraprostatic Lesion (DIL) in Localized Carcinoma Prostate Treated with Stereotactic Body Radiotherapy
Papaiah Susheela Sridhar et al. | ASTRO | 2025
Optimizing PTV Generation and Comparison of OAR Dosimetry with Different Rectal Spacers in Patients Treated with HDR-Like Prostate SBRT
Emily Hollis et al. | ASTRO | 2025
Stereotactic Body Radiation Therapy to Only Prostate and Proximal Seminal Vesicles is a Viable Option for a Favorable Subset of High-Risk Prostate Cancer Patients
Nima Aghdam et al. | ASTRO | 2025
To Space or Not to Space: The EPIC question for Prostate Stereotactic Radiation (SBRT) with or without Hydrogel Rectal Spacer (RS)
Madeline Flanagan et al. | ASTRO | 2025
MRI PI-RADS Lesion Location in Transitional vs. Peripheral Zone and Impact on Acute GU Toxicity Following Prostate SBRT Microboost
Jonathan Lischalk et al. | ASTRO | 2025
Stereotactic Reirradiation with CyberKnife for Locally Recurrent Prostate Cancer, Long-term Toxicity and Clinical Outcomes from a Monocentric Cohort
Francolini G, Carnevale MG, Di Cataldo V, Loi M, Detti B, Orsatti C, Caprara L, Bertini N, Lorenzetti V, Olmetto E, Becherini C, Visani L, Salvestrini V, Simontacchi G, Greto D, Bonomo P, Doro R, Masi L, Desideri I, Meattini I, Serni S, Livi L | Radiol Med | 2023
Intensity Modulated Radiation Therapy with Stereotactic Body Radiation Therapy Boost for Unfavorable Prostate Cancer: Five-year Outcomes
Carrasquilla M, Sholklapper T, Pepin AN, Hodgins N, Lei S, Rashid A, Danner M, Zwart A, Bolanos G, Ayoob M, Yung T, Aghdam N, Collins B, Suy S, Kumar D, Hankins R, Kowalczyk K, Dawson N, Collins S | Front Oncol | 2023
Dosimetric Comparison of CyberKnife and Conventional Linac Prostate Stereotactic Body Radiation Therapy Plans: Analysis of the PACE-B Study
Ratnakumaran R, Sasitharan A, Khan A, Mayet H, Mohajer J, Hinder V, Brand DH, Fullarton R, Loblaw A, Hall E, van As N, Tree AC; PACE trial investigators | Int J Radiat Oncol Biol Phys. | 2025
